Hydroxychloroquine Sulfate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029
Hydroxychloroquine Sulfate: The Rescuer in COVID-19 Crisis
Hydroxychloroquine (HCQ), is a drug used to forestall and treat jungle fever in zones where intestinal sickness stays touchy to chloroquine. Other utilizations incorporate treatment of rheumatoid joint pain, lupus, and porphyria cutanea tarda. Furthermore, hydroxychloroquine sulfate is the highly touted drug that's taken for center stage due to its potential to treat patients with COVID-19. As result of this demand for hydroxychloroquine sulfate has begun to increase since last two months after US President Donald Trump has announced its effectiveness in treating corona virus patients. It is predominantly sold as a sulfate salt known as hydroxychloroquine sulfate. Brand names of hydroxychloroquine include Plaquenil, Hydroquin, Axemal (in India), Dolquine, Quensyl, Quinoric.
India is amongst the leading producer of hydroxychloroquine sulfate across globe and has suspended this drug export in March 2020. However, Indian hydroxychloroquine sulfate manufacturer rely on China for raw material supplies. Market for hydroxychloroquine sulfate is experiencing mounting growth in 1st quarter of 2020, backed by high demand for treating nCoV-19 patients.
Global Hydroxychloroquine Sulfate Market to Gain Traction as COVID-19 Outbreak Medication
After COVID-19 outbreak, utilization of hydroxychloroquine, a medication previously endorsed to treat malaria and rheumatoid joint inflammation has picked prominence. The endorsement came at the encouragement of US President Donald Trump. Some little examinations have recommended it can assist patients with COVID-19, yet concrete evidence are still worked upon.
That hasn't stopped the Department of Health and Human Services from tolerating 30 million gave portions from Novartis' Sandoz unit, just as another 1 million tablets of chloroquine phosphate, the other type of the medication. Bayer, Mylan and Amneal have each swore gifts or expanded creation of the medications. The outcomes from a fake treatment controlled preliminary of hydroxychloroquine for COVID-19 show that patients hospitalized with gentle disease recouped more rapidly with expansion of the medication than with fake treatment toward the beginning of a standard treatment. The outcomes additionally recommend that hydroxychloroquine may pass on some security against the ailment intensifying.
Segmentation Analysis of Global Hydroxychloroquine Sulfate Market
Hydroxychloroquine Sulfate Market is bifurcated into three major categories: Purity level, Application and region.
On the basis of purity level, the global market for hydroxychloroquine sulfate is divided into:
On the basis of Application, the global market for hydroxychloroquine sulfate is categorized as:
Hydroxychloroquine Sulfate Market: Regional Outlook
Asia Pacific region dominates the production of hydroxychloroquine sulfate followed by North America. India and China are considered as leading manufacturer, backed by its usual demand of hydroxychloroquine sulfate for curing malaria patients. India's Directorate General of Foreign Trade on March 25 prohibited the fare of Hydroxychloroquine yet said that specific shipments on compassionate grounds might be permitted dependent upon the situation. With increasing number of Covid-19 patients U.S., Italy, Spain and other countries across the globe can be seen as the target market for hydroxychloroquine sulfate. Individuals from the SAARC alliance, Indonesia and the UAE have mentioned India to lift the fare prohibition on hydroxychloroquine, as they gaze at a deficiency of the medication fundamentally utilized for rheumatoid joint inflammation and long haul immune system infection lupus. Furthermore, a few other European nations have likewise mentioned India for the inventory of hydroxychloroquine.
Key Players of Hydroxychloroquine Sulfate Market
Generics organizations Mylan and Teva Pharmaceutical Industries have demonstrated their pledge to battling the COVID-19 pandemic by making declarations around hydroxychloroquine sulfate tablets, which the two of them manufacture. Mylan has restarted production of the tablets at its West Virginia fabricating office in the USA, so as to meet the potential for expanded interest coming about because of potential adequacy of the item in treating cases. Other global prominent players Novartis, Ipca Laboratories Ltd. and Mylan have announced taking steps to scale up production capacity to meet mounting demand across the globe. With increasing opportunities and growing future scope will increase the competitiveness of market, adding number of hydroxychloroquine sulfate manufacturers across the globe.
The research report presents a comprehensive assessment of the hydroxychloroquine sulfate market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. This hydroxychloroquine sulfate market report provides analysis and information, according to market segments such as purity level, application and region.
The Global Hydroxychloroquine Sulfate Market Report Covers Exhaustive Analysis On:
The hydroxychloroquine sulfate market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The global hydroxychloroquine sulfate market report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The global hydroxychloroquine sulfate market report also maps the qualitative impact of various market factors on market segments and geographies.
The Global Hydroxychloroquine Sulfate Market Report Highlights:
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report